Tech Company Financing Transactions

Axikin Pharmaceuticals Funding Round

Axikin Pharmaceuticals closed a $1.5 million venture capital round on 6/30/2009. Investors included Sanderling Ventures.

Transaction Overview

Announced On
6/30/2009
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors

Sanderling Ventures (Peter McWilliams)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10835 Road To The Cure 250
San Diego, CA 92121
USA
Email Address
Not Recorded
Overview
Axikin Pharmaceuticals develops small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases.
Profile
Axikin Pharmaceuticals LinkedIn Company Profile
Social Media
Axikin Pharmaceuticals Company Twitter Account
Company News
Axikin Pharmaceuticals News
Facebook
Axikin Pharmaceuticals on Facebook
YouTube
Axikin Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
President
Kevin Bacon
  Kevin Bacon LinkedIn Profile  Kevin Bacon Twitter Account  Kevin Bacon News  Kevin Bacon on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2009: Kalido venture capital transaction
Next: 6/30/2009: PumpkinHead venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary